Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil
- 15 July 1988
- Vol. 62 (2) , 266-269
- https://doi.org/10.1002/1097-0142(19880715)62:2<266::aid-cncr2820620207>3.0.co;2-y
Abstract
Cardiac symptoms, including hypotension, developed in three patients with advanced colorectal carcinoma while being treated with cisplatin (CDDP) and 5-fluorouracil (5-FU). In two patients, hypotension was associated with severe left ventricular dysfunction. All three patients required therapy discontinuation. Cardiac enzymes remained normal despite transient electrocardiographic (EKG) changes. The presentation and cardiac evaluation (hemodynamic, echocardiographic, and scintigraphic) of these patients suggest new manifestations of 5-FU cardiotoxicity that may be influenced by CDDP. The possible pathophysiologic mechanisms are discussed.This publication has 16 references indexed in Scilit:
- Acute Vascular Ischemic Events After Cisplatin-Based Combination Chemotherapy for Germ-Cell Tumors of the TestisAnnals of Internal Medicine, 1986
- Coronary insufficiency and 5-fluorouracil therapy: A case report, review, and suggestion regarding mechanismCleveland Clinic Journal of Medicine, 1983
- Cardiac Toxicity of 5-Fluorouracil: A Study on 1083 PatientsTumori Journal, 1982
- Antitumor chemotherapy after fluorouracil anginaZeitschrift für Krebsforschung und Klinische Onkologie, 1982
- 5-Fuorouracil CardiotoxicityTumori Journal, 1979
- Fluorouracil cardiotoxicity.BMJ, 1978
- Fluorouracil cardiotoxicity.BMJ, 1978
- CARDIOTOXICITY OF 5-FLUOROURACILThe Lancet, 1977
- 5-FLUOROURACIL AND ANGINAThe Lancet, 1975
- cis-Platinum (II) DiamminedichloridePublished by Springer Nature ,1974